Evaluation of the Increase of the Driving Speed With Walkaide® Medical Device
WALKAIDE
1 other identifier
interventional
40
1 country
1
Brief Summary
Evaluation of the increase of the driving speed after apparatus by Walkaide® medical device in deficits levator foot of central origin.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for phase_1
Started Sep 2013
Typical duration for phase_1
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2013
CompletedFirst Submitted
Initial submission to the registry
December 21, 2015
CompletedFirst Posted
Study publicly available on registry
December 24, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2016
CompletedDecember 24, 2015
December 1, 2015
2.3 years
December 21, 2015
December 23, 2015
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in walking speed
The main objective is the study of changes in walking speed on the 6-minute walk test between the initial walk without orthotics and walking with Walkaide® functionnal electric stimulation orthosis after one month of training.
One month
Study Arms (1)
WALKAIDE
EXPERIMENTALA clinical evaluation will be conducted at T0 with achievement of the following tests without orthosis and with the usual orthosis if applicable: he will be made a stimulation test of common peroneal nerve and settings Walkaide® device. Subjects will be reconvened at T1, one to four weeks after the initial assessment to ensure the stability of walking speed. We will perform the following tests without orthosis and with the usual orthosis if applicable. The final evaluation (T2) will be 28 days after the start of the port of the device.
Interventions
A clinical evaluation will be conducted at T0 with achievement of the following tests without orthosis and with the usual orthosis if applicable: he will be made a stimulation test of common peroneal nerve and settings Walkaide® device. Subjects will be reconvened at T1, one to four weeks after the initial assessment to ensure the stability of walking speed. We will perform the following tests without orthosis and with the usual orthosis if applicable. The final evaluation (T2) will be 28 days after the start of the port of the device.
Eligibility Criteria
You may qualify if:
- Passive ankle dorsiflexion of at least 0 ° (strained knee)
- No injection of botulinum toxin in the lower limbs for at months 3 months
- No surgery for at least three months
- Walk 10 meters in less than 60 seconds, without human help, with or without technical assistance
- Score the Functional Ambulation Classification (FAC) ≥ 3
- Ashworth Score ≤ 2 sural triceps
- Written consent signed
You may not qualify if:
- Presence of severe cognitive impairment that does not allow the use of the device independently
- History of debilitating disease associated general
- Local embarrassing skin disorder laying the electrodes
- Pacemaker
- Unstable Epilepsy
- Pregnancy and lactation
- Participation Refusal
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Les Capucins
Angers, Pays de la Loire Region, 49103, France
Related Publications (5)
Stein RB, Everaert DG, Thompson AK, Chong SL, Whittaker M, Robertson J, Kuether G. Long-term therapeutic and orthotic effects of a foot drop stimulator on walking performance in progressive and nonprogressive neurological disorders. Neurorehabil Neural Repair. 2010 Feb;24(2):152-67. doi: 10.1177/1545968309347681. Epub 2009 Oct 21.
PMID: 19846759RESULTDetrembleur C, Dierick F, Stoquart G, Chantraine F, Lejeune T. Energy cost, mechanical work, and efficiency of hemiparetic walking. Gait Posture. 2003 Oct;18(2):47-55. doi: 10.1016/s0966-6362(02)00193-5.
PMID: 14654207RESULTKottink AI, Oostendorp LJ, Buurke JH, Nene AV, Hermens HJ, IJzerman MJ. The orthotic effect of functional electrical stimulation on the improvement of walking in stroke patients with a dropped foot: a systematic review. Artif Organs. 2004 Jun;28(6):577-86. doi: 10.1111/j.1525-1594.2004.07310.x.
PMID: 15153151RESULTEveraert DG, Thompson AK, Chong SL, Stein RB. Does functional electrical stimulation for foot drop strengthen corticospinal connections? Neurorehabil Neural Repair. 2010 Feb;24(2):168-77. doi: 10.1177/1545968309349939. Epub 2009 Oct 27.
PMID: 19861590RESULTSabut SK, Lenka PK, Kumar R, Mahadevappa M. Effect of functional electrical stimulation on the effort and walking speed, surface electromyography activity, and metabolic responses in stroke subjects. J Electromyogr Kinesiol. 2010 Dec;20(6):1170-7. doi: 10.1016/j.jelekin.2010.07.003. Epub 2010 Aug 6.
PMID: 20692180RESULT
Study Officials
- PRINCIPAL INVESTIGATOR
Isabelle Richard, md-PHD
University Hospital, Angers
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- phase 1
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER GOV
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 21, 2015
First Posted
December 24, 2015
Study Start
September 1, 2013
Primary Completion
January 1, 2016
Study Completion
January 1, 2016
Last Updated
December 24, 2015
Record last verified: 2015-12